Evidence map›Paper›PMID 32145028›Full record

ArticleMolecular biology and evolution2020

Mammalian Alternative Translation Initiation Is Mostly Nonadaptive.

Chuan Xu, Jianzhi Zhang

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology and evolution, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Gene product diversity: adaptive or not?Trends in genetics : TIG · 2022
    Review
  11. Article
  12. Review
  13. Article
  14. Non-Darwinian Molecular Biology.Frontiers in genetics · 2022
    Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chuan XuDepartment of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI.
Jianzhi ZhangDepartment of Ecology and Evolutionary Biology, University of Michigan, Ann Arbor, MI.
University of Michigan–Ann Arbor · US

Funding

Position effects on gene expression level and noiseR01GM120093 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ZHANG, JIANZHI · 2016 to 2019
$1.2M
NIGMS NIH HHS R01 GM120093
6 · The paper itself

Abstract

Alternative translation initiation (ATLI) refers to the existence of multiple translation initiation sites per gene and is a widespread phenomenon in eukaryotes. ATLI is commonly assumed to be advantageous through creating proteome diversity or regulating protein synthesis. We here propose an alternative hypothesis that ATLI arises primarily from nonadaptive initiation errors presumably due to the limited ability of ribosomes to distinguish sequence motifs truly signaling translation initiation from similar sequences. Our hypothesis, but not the adaptive hypothesis, predicts a series of global patterns of ATLI, all of which are confirmed at the genomic scale by quantitative translation initiation sequencing in multiple human and mouse cell lines and tissues. Similarly, although many codons differing from AUG by one nucleotide can serve as start codons, our analysis suggests that using non-AUG start codons is mostly disadvantageous. These and other findings strongly suggest that ATLI predominantly results from molecular error, requiring a major revision of our understanding of the precision and regulation of translation initiation.

Indexed as

Peptide Chain Initiation, TranslationalAnimalsGenetic VariationHumansMammalsMiceSelection, GeneticTranscription Initiation Siteevolutionmolecular errornatural selectionstart codontranslational amount

Identifiers

PMID32145028
PMCPMC7828576
OpenAlexW3009811541

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.